Transgene starts cervical cancer Phase II

Transgene (NM:Transgene; TRGNY) began in Mexico a 57-patient Phase II trial

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE